These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


674 related items for PubMed ID: 16964262

  • 21. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.
    Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B.
    Nature; 2003 Aug 14; 424(6950):743-8. PubMed ID: 12872135
    [Abstract] [Full Text] [Related]

  • 22. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD, Vandenplas ML, Hurley DJ, Moore JN.
    Vet Immunol Immunopathol; 2009 Jan 15; 127(1-2):125-34. PubMed ID: 19019456
    [Abstract] [Full Text] [Related]

  • 23. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.
    Hall C, Flores MV, Chien A, Davidson A, Crosier K, Crosier P.
    J Leukoc Biol; 2009 May 15; 85(5):751-65. PubMed ID: 19218482
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Signalling of toll-like receptors.
    Brikos C, O'Neill LA.
    Handb Exp Pharmacol; 2008 May 15; (183):21-50. PubMed ID: 18071653
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. MAPPIT analysis of early Toll-like receptor signalling events.
    Ulrichts P, Tavernier J.
    Immunol Lett; 2008 Mar 15; 116(2):141-8. PubMed ID: 18221795
    [Abstract] [Full Text] [Related]

  • 35. Pathological role of Toll-like receptor signaling in cerebral malaria.
    Coban C, Ishii KJ, Uematsu S, Arisue N, Sato S, Yamamoto M, Kawai T, Takeuchi O, Hisaeda H, Horii T, Akira S.
    Int Immunol; 2007 Jan 15; 19(1):67-79. PubMed ID: 17135446
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K.
    J Endotoxin Res; 2005 Jan 15; 11(1):51-5. PubMed ID: 15826379
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
    J Med Virol; 2008 Jun 15; 80(6):980-8. PubMed ID: 18428149
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 34.